Teva Neuroscience, Inc., introduces the AZILECT® (rasagiline tablets) Case Study App for Speakers. This App was designed to provide AZILECT speakers with a tool for presenting interactive case studies to individuals or groups of health care providers participating in promotional programs about the role of AZILECT in the management of Parkinson’s disease. The App content is secure and can...more

Teva Neuroscience, Inc., introduces the AZILECT® (rasagiline tablets) Case Study App for Speakers. This App was designed to provide AZILECT speakers with a tool for presenting interactive case studies to individuals or groups of health care providers participating in promotional programs about the role of AZILECT in the management of Parkinson’s disease. The App content is secure and can only be accessed by the 2013 AZILECT Speaker Bureau. To access the full Prescribing Information, or for more information regarding AZILECT, please visit www.azilect.com.

less